- Congratulations to Turnstone Biologics in Series B Financing
- Turnstone Biologics has closed USD $41M in Series B Financing.
- McMaster Technology Licensee, Turnstone Biologics, Closes $11.3M Investment
- Turnstone Biologics Inc. announced the completion of an $11.3 million Series A financing round led by Versant Ventures with follow-on capital committed in excess of $20.0 million. Turnstone is commercializing a technology developed by Dr. Brian Lichty, McMaster University, Dr. John Bell, Ottawa Hospital Research Institute, and Dr. David Stojdl, Children’s Hospital of Eastern Ontario.
- Moving Mac’s Microwave Radar Technology to the Global Marketplace
- Danelle D’Alvise, Research Communications July 17, 2015